On admission, concentrations of alkaline phosphatase (ALP) and γ-glutamil transpeptidase were increased.
Five clinical prediction rules were calculated and admission concentrations of procalcitonin (PCT), C-reactive protein, neutrophil-lymphocyte count ratio (NLCR), lymphocyte count, white blood cell count, and red blood cell distribution width were measured.
On admission, concentrations of I-FABP (1,395 ± 438 pg/ml) were significantly (P < 0.05) elevated in patients with ISS > 25 +AI compared with all other groups on admission (ISS > 25 -AI: 309 ± 67 pg/ml; ISS < 25 +AI: 531 ± 202 pg/ml; ISS < 25 -AI: 221 ± 46 pg/ml) (MWU).
Briefly, on admission, concentrations of MR-proADM and CT-proET-1 were shown to increase gradually in correlation with severity ranging from systemic inflammatory response syndrome (SIRS) to severe forms of sepsis or with the pneumonia severity index (PSI) [ 13, 14, 21].
An admission glucose concentration of 112 mg/dL was associated with 20% mortality, a glucose concentration above 142 mg/dL was associated with 45% mortality, and patients with glucose concentrations in between had 29% mortality.
Pearson x2 analysis of data for 48 patients with SCI indicated that hyperglycemia on admission (glucose concentration ≧ 126 mg/dl) was a significant risk predictor of poor functional outcome.
Diabetics, admission norepinephrine concentration and high first residual tacrolimus dosage are significant independent predictive factors for RRT (respective OR of 3.75 (1.15 to −12.12), 2.04 (1.13 to −3.69) and 1.07 (1.05 to −1.09) per point of tacrolimus).
In this study we sought to further describe the spectrum of toxicity and clinical outcomes relative to the admission plasma concentration in patients with acute imidacloprid poisoning.
